News Releases

  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms

News tagged ‘GraftVersusHost’ clear

  • A new technique being tested in stem-cell transplants from imperfectly matched donors reveals an unforeseen response that can suppress GVHD.

Tags: GraftVersusHost

  • A drug used in multiple myeloma treatment may outperform other therapies in transplant patients who had unrelated, partially matched donors.

Tags: GraftVersusHost

  • In a study that seems to pivot on a paradox, scientists at Dana-Farber Cancer Institute have used an immune system stimulant as an immune system suppressor to treat a common, often debilitating side effect of donor stem cell transplantation in cancer patients.

Tags: BasicResearch, GraftVersusHost, ImmuneSystem

  • Dana-Farber researchers found that an experimental drug combination for preventing graft-versus-host disease (GVHD) was not significantly better than the standard regimen of care, but that the new combination could provide an alternative that could be preferable in certain scenarios.

Tags: GraftVersusHost, StemCellTransplant, Leukemia

  • Dana-Farber researchers detail how low doses of interleukin-2 (IL-2) can alleviate chronic graft-versus-host disease (GVHD) and possibly lead to better treatment for other immune disorders.

Tags: GraftVersusHost

  • Dana-Farber researchers find adding bortezomib to standard preventive therapy for graft-versus-host-disease (GVHD) results in improved outcomes for some patients.

Tags: GraftVersusHost, StemCellTransplant

  • Dana-Farber researchers found that adding bortezomib to initial treatment for chronic graft-versus-host disease allowed significant reduction of steroid medication in some patients.

Tags: GraftVersusHost, StemCellTransplant

Showing 1-7 of 7 items